TB-500 Peptide | TB 500 Research Peptides

Molecular Characteristics and Technical Information

Molecular Properties and Technical Details For maximum scientific accuracy and reproducibility across international research jurisdictions, the molecular composition of TB500 must meet precise chemical specifications. Here are its specific features.

TB-500 Peptide Chemical Specifications

Structural Presentation

Peptides are typically provided with an Ac-acetylated N-terminus sequence, similar to what occurs naturally endogenously within thymosin peptide family members. This modification increases resistance against exopeptidases present in experimental culture media and extends their half-life during prolonged in vitro assays.

TB500 Peptide

Cell and molecular biology is heavily reliant upon highly purified, structurally stable synthetic peptides for research. Of these biochemical tools, one that stands out as particularly noteworthy among academic and industrial inquiry is TB500, an analogue of naturally occurring sequence used worldwide in in vitro and in vivo laboratory models to investigate structural biology, cell migration, tissue-matrix interactions.

Biochemical research institutions, universities, and contract research organizations (CROs) across the United States, Canada, Australia, and United Kingdom need reliable high-purity reagents in order to produce repeatable experimental data. Variations in peptide synthesis workflows or purification protocols may introduce confounding variables into complex assay systems that may introduce confounding variables.

This comprehensive technical overview serves as an authoritative reference on the structural, chemical, and manufacturing standards of TB500 peptide; setting parameters necessary for rigorous laboratory experimentation.

What Is TB500 Peptide?

TB500 is a synthetic peptide designed to mimic the primary active region of Thymosin Beta-4 (Tb4), an abundant and ubiquitous 43-amino acid protein found throughout various cell matrix sites. Structurally, TB500 represents a short fragment from this full-length protein isolated specifically to study molecular mechanisms related to actin binding and cytoskeleton modulation.

As a research peptide, TB500 is produced using precise solid-phase methodology to ensure its exact replication of its targeted sequence. Used in laboratory environments, TB500 serves as a molecular tool to examine physiological signaling pathways without the complex structural complexity often found with larger macromolecular proteins. Recognized within the biochemistry community for being highly stable yet short biomolecule that allows targeted observation of localized cellular dynamics, it has become a must have in research environments worldwide.

TB500 Peptide Overview

Thymosin Beta-4 was initially isolated from thymus gland, while its shorter synthetic derivative, TB500, has become the go-to analogue for targeted biochemical analysis. The primary benefit of using TB500 in laboratory research stems from its reduced molecular weight compared to that of its parent protein; thus altering biophysical properties, diffusion rates and interaction kinetics within experimental media.

Research demonstrates that TB500 maintains the essential actin-binding motif present in full-length thymosin proteins. By binding with G-actin (globular actin), this peptide serves as a primary model for studying actin polymerization regulation – an essential process governing cell morphology, motility and intracellular transport systems.

Research Applications of TB500 Peptide

Laboratory applications for the TB500 research peptide span multiple disciplines within cell biology, biophysics and molecular biochemistry. Researchers typically use this molecule to elucidate specific cascades governing structural cell adaptations.

Actin Polymerization and Cytoskeletal Dynamics

One key focus of research involving TB500 involves its role as an actin-sequestration agent. Both in cell-free assays and cell cultures, this peptide binds directly to monomeric G-actin in 1:1 ratio and prevents its unregulated polymerization into F-actin (filamentous actin). Researchers employ this mechanism to study how cells maintain unpolymerized actin subunit pools essential for understanding protrusion, lamellipodia formation and intracellular trafficking mechanisms.

Cell Migration and Chemotaxis

By controlling actin monomer availability, TB500 influences both the rate and directionality of cell migration. Academic laboratories utilize transwell migration assays and scratch-wound models to study how exogenous application of this peptide changes endothelial cells, fibroblasts, keratinocytes migratory velocity. Furthermore, these studies help map downstream signaling cascades, including activation of focal adhesion kinases (FAK) and mitogen-activated protein kinases (MAPK) pathways.

Angiogenesis and Endothelial Cell Differentiation

Within vascular biology models, TB500 is employed to examine morphological changes associated with angiogenesis – the process by which new blood vessels form from preexisting ones. Human umbilical vein endothelial cells (HUVECs) allow researchers to observe its effect on endothelial cell differentiation, tube formation, matrix metalloproteinase (MMP) expression levels as well as baseline proliferation factors. These analyses contribute valuable data in understanding baseline proliferation factors and baseline factors associated with baseline vascular proliferation factors.

TB500 Peptide Manufacturing Process

As a leading TB500 peptide producer, our production protocol utilizes cutting-edge Solid-Phase Peptide Synthesis (SPPS) combined with advanced purification and stabilization methodologies. Achieving high purity products requires adhering strictly to multi-step chemical procedures.

1. Chain Extinction with SPPS

Synthesis begins on a solid-state resin support (typically Fmoc-protected amino acids attached to Wang or Rink amide resin), wherein the peptide chain is synthesized from its C-terminus through to its N-terminus via sequential cycles of:

Deprotection: Elimination of an N-terminal protecting group by means of a base solution such as piperidine.

Coupling: Utilization of coupling reagents such as HATU or DIC for activation of the amino acid followed by reaction with resin-bound peptide.

2. Cleavage and Deprotection

Once the targeted sequence has been assembled, its assembly is separated from its solid resin support using a cleavage cocktail comprising Trifluoroacetic Acid (TFA) and triisopropylsilane/water as scavenger molecules to capture reactive carbocations sites and prevent side-reactions at sensitive residues like methionine and tryptophan.

3. Preliminary Chromatographic Purification

Crude peptide mixtures typically include short sequences and deletion peptides that need to be isolated in order to produce pure target molecules. To do this, preparative Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) with specially tailored C18 or C8 stationary phases and accurate gradient elution profiles is utilized; target fractions can then be isolated at high resolution.

4. Lyophilization.

Once purified aqueous fractions containing peptide are isolated from contaminants, they undergo a controlled freeze-drying process to produce TB500 Lyophilized Powder. This includes freezing it to ultra-low temperatures before subjecting it to both primary and secondary drying phases under vacuum; sublimation removes water via this method, creating an extremely stable white cake-like powder suitable for long-term storage with rapid reconstitution capabilities.

Quality Control Standards

Quality controls must be uncompromising in order to provide reliable research peptides to top academic and industrial laboratories, so every batch of synthetic TB500 must go through stringent analytical validation to verify chemical integrity.

Analytical instrumentation is regularly calibrated against international standards to ensure minimal variation from batch-to-batch variation, giving researchers confidence in their experiments.

Certificate of Analysis (COA) Details

Every shipment of TB500 peptide comes complete with its own Certificate of Analysis (COA). This document serves to verify its chemical profile and represents our guarantee of purity and identity.

An average COA should include:

• Product Name and Lot Number: Exact matches between these identifiers and physical vial labels are required for verification.
• HPLC Chromatogram: This visual trace illustrates baseline separation of peptide peak, verifying percentage purity through peak area quantification.
• Mass Spectrometry (MS) Spectrum: A mass-to-charge plot validating the exact molecular mass of a synthesized compound and ascertaining that there have been no major structural mutations during synthesis.
• Solubility Profile: An initial empirical assessment of reconstitution parameters in either sterile water or buffered saline solutions.

Storage and Handling Guidelines

Lyophilized peptides, while generally stable, may become vulnerable to physical degradation, oxidation and hydrolysis if stored or handled incorrectly. To ensure maximum shelf life and activity for their TB500 lyophilized powder products, laboratories should implement specific storage protocols:

Long-Term Storage of Unreconstituted Powder

Temperature: Store items between -20℃ and -80℃ in a manual defrost freezer to prevent moisture accumulation and accelerate degradation. Please do not use auto-defrost cycles, as their fluctuations could cause condensation build-up and accelerate degeneration.

Atmosphere: Dehumidify the container. Store vials tightly sealed in an airtight moisture-resistant box containing silica gel desiccant packs for moisture control.

Shelf Life: Under optimal cryogenic storage conditions, lyophilized TB500 remains stable for 24-36 months after it has been frozen in powder form.

Reconstitution Protocols

Before opening the vial, allow it to acclimate to room temperature within a desiccator in order to prevent atmospheric moisture from condensing onto the lyophilized cake and leading to hydrolytic bond cleavage.

• Solvent Selection: Reconstitute using either sterile, deoxygenated lab-grade water (ddH2O) or low-ionic strength phosphate-buffered saline (PBS), depending on your downstream assay needs.
• Mechanical Handling: When injecting solvent down the inner glass wall of the vial rather than directly on powder, gently swirl to dissolve cake. Do not vortex or shake violently as high shear forces can induce mechanical denaturation and aggregate formation of the peptide chains.

Short-Term Storage (Reconstituted Solution)

• Temperature: Store short-term supplies at 4℃ for up to 7-10 days of use.
• Freezing Aliquots: When working with extended experiments, divide reconstituted stock into single-use aliquots and store at either -20℃ or -80℃ for long-term storage. Avoid repeated freeze-thaw cycles that disrupt peptide bonds and decrease functional purity.

Packaging and Custom Manufacturing Options

Understanding that different research projects necessitate unique experimental formats, we offer flexible procurement and structural design pathways for global laboratory clients.

Standard Presentation

Our standard catalog offerings feature single or bulk glass vials containing ultra-pure lyophilized powder sealed under an inert gas blanket (usually argon or nitrogen) with flip-off aluminum crimp caps to maintain an anaerobic environment until reconstitution occurs.

Custom Peptide Manufacturing Services

Research protocols often necessitating nonstandard specifications can take advantage of our custom peptide manufacturing platform for tailored synthesis criteria:

• Specific Counterion Exchange: Converting from TFA salts to acetate or hydrochloride forms to reduce potential cytotoxicity in specific cell culture environments.
• Vial Customization: Create custom mass configurations such as 2 mg, 5 mg or 10 mg in individual or bulk multi-gram compounding vials.
• Labeling and Conjugation: Integrating fluorescent tags (FITC, Cy3, Cy5) or biotinylation to track and image studies within advanced fluorescence microscopy workflows.

Why Select a Reputable TB500 Peptide Manufacturer

Partnership with an established, professional custom peptide manufacturing enterprise ensures strict adherence to operational parameters for biochemical research tools.

Industrial Synthesis Standards: A research peptide’s chemical integrity determines its baseline reliability in subsequent experiments; substandard material can introduce artifacts which compromise reproducibility.

Selecting a supplier with extensive expertise ensures.

1. State-of-the-Art Synthesizers: Automated synthesis matrices eliminate human error and ensure uniform chain assembly.
2. Strict Global Logistics: Provision of reliable cold-chain shipping management ensuring reagents reach facilities in the US, Canada, Australia and UK without thermal compromise.
3. Traceable Documentation: Comprehensive analytical tracking from raw material acquisition through product distribution, with verifiable chain of custody documentation for audit compliance purposes.

Published Research Overviews

Thymosin Beta-4 fragments and synthetic analogues such as TB500 have become the subject of extensive academic discussion in peer-reviewed biochemical literature. Research across structural biology journals examines how these fragments interact with actin binding sites and whether varying sequences affect thermodynamic binding constants (Kd).

Researchers often conduct comparative structural analyses demonstrating the functional redundancies and transport differences between full-length proteins and synthetic fractions, serving as foundational data for current cellular mechanics projects.

Research Peptides

Laboratories often evaluate TB500 alongside complementary biochemical sequences to conduct comprehensive, multivariable studies; this helps facilitate comprehensive yet flexible study designs.

• Thymosin Beta-4 (Full-Length): This native 43-amino acid sequence serves as an authoritative control to assess baseline efficacy in synthetic fragments truncated from it.
• BPC 157 is an extensively studied pentadecapeptide fragment used to study extracellular matrix transformations and tissue-remodeling interactions in different physiological models.
• Thymosin Alpha-1: An immunomodulatory peptide isolated from the same tissue source used in comparative tracking studies that investigate intracellular signaling pathways.

TB500 Peptide Frequently Asked Questions

1. What is the standard purity level of your stock TB500 peptide?

Our standard inventory of TB500 peptide is manufactured to meet an ultra-high purity threshold of ≥98.0%, as determined by analytical reverse-phase High-Performance Liquid Chromatography (RP-HPLC). As an established custom peptide manufacturer, we understand that chemical purity is paramount to eliminating variables in delicate in vitro assays and molecular research. For specialized laboratory applications requiring even more stringent parameters, we can accommodate custom synthesis requests for purities reaching up to 99%. Every batch undergoes meticulous purification workflows to ensure consistent, reproducible data across all your experimental models.

2. Can your facility accommodate bulk supply orders for the TB500 peptide?

Yes, our state-of-the-art solid-phase peptide synthesis (SPPS) facility is fully equipped to scale production from small milligram research aliquots up to multi-gram and kilogram bulk supply volumes. We partner with contract research organizations (CROs), academic institutions, and industrial biotechnology firms worldwide to provide reliable wholesale supply chains. Bulk TB500 peptide procurement benefits from tiered pricing structures and dedicated quality control batch testing, ensuring that large-scale, long-term laboratory studies maintain complete consistency from the first assay to the last. Contact our corporate accounts team to discuss your specific volume requirements.

3. What analytical testing do you perform to verify the identity of the TB500 peptide?

To verify the absolute chemical identity and structural integrity of each synthesized batch of TB500 peptide, we subject the material to rigorous mass spectrometry validation, specifically Electrospray Ionization Mass Spectrometry (ESI-MS). This analytical method measures the exact mass-to-charge ratio of the molecule, confirming that the synthesized sequence matches the theoretical molecular weight of approximately 4967.44 g/mol. By pairing mass spectrometry with high-resolution chromatography, we guarantee that the final product is free from structural mutations, deletion sequences, or unexpected synthesis artifacts before it is released to your laboratory.

4. Is a Certificate of Analysis (COA) provided with every TB500 peptide shipment?

Absolutely. Every batch of TB500 peptide dispatched from our facility is accompanied by a comprehensive, lot-specific Certificate of Analysis (COA). This document provides full transparency into the biochemical profile of the product. The COA includes the raw analytical data from our quality control department, featuring the actual High-Performance Liquid Chromatography (HPLC) chromatogram for purity validation and the Mass Spectrometry (MS) spectrum for identity verification. It also documents essential technical metrics such as moisture content, net peptide content, and counterion presence, providing full traceability for your laboratory audits.

5. What are the recommended storage guidelines for TB500 lyophilized powder?

To maintain long-term molecular stability and prevent degradation, unreconstituted TB500 lyophilized powder must be stored in a secure, manual-defrost freezer at -20℃ or -8℃ . It is crucial to store the vials inside a tightly sealed container containing silica gel desiccant packs to mitigate any atmospheric moisture exposure. Avoid auto-defrost freezers, as their cyclic temperature fluctuations can introduce humidity and accelerate peptide hydrolysis. When stored under these optimal cryogenic and desiccated conditions, the synthetic peptide will maintain its chemical integrity and baseline purity for up to 36 months.

6. Do you offer OEM and white-label manufacturing services for TB500 peptide?

Yes, we offer comprehensive Original Equipment Manufacturer (OEM) and white-label manufacturing workflows for corporate partners and distribution networks. Our services allow you to leverage our advanced synthesis infrastructure while branding the final product under your company’s portfolio. We provide custom vial sizing, bespoke labeling configuration, variable lyophilization cake appearances, and specialized packaging design that meets international shipping standards. All OEM partnerships are protected by strict non-disclosure agreements (NDAs), ensuring your proprietary distribution channels and custom formulations remain entirely confidential while maintaining peak manufacturing compliance.

7. What is the advantage of sourcing TB500 as a lyophilized powder?

Sourcing TB500 peptide in its lyophilized (freeze-dried) powder state offers significant advantages regarding chemical stability, shelf life, and ease of transit. The lyophilization process removes water via sublimation under an ultra-high vacuum, locking the peptide into an amorphous, stable structural matrix. This form drastically minimizes the risk of hydrolytic cleavage and enzymatic degradation that naturally occurs when peptides are left in an aqueous solution. Lyophilized powder allows for predictable room-temperature shipping profiles and gives researchers the flexibility to reconstitute the molecule using their preferred laboratory buffers.

8. How is the TB500 peptide packaged to ensure stability during international transit?

We utilize specialized laboratory packaging protocols to shield the TB500 peptide from environmental stressors during international distribution to the US, Canada, Australia, and the UK. Each synthetic batch is sealed in high-durability borosilicate glass vials under an anhydrous, inert gas blanket—typically nitrogen or argon—to prevent oxidation. The vials are secured with heavy-duty aluminum crimp caps and flip-off seals. For shipping, the vials are placed in temperature-controlled, shock-absorbent containers, ensuring the product arrives at your research institution without thermal or mechanical compromise.

9. Can I request a specific counterion, such as acetate, for custom TB500 peptide synthesis?

Yes, our custom peptide manufacturing platform allows researchers to specify the exact counterion salt form required for their unique experimental designs. While standard solid-phase peptide synthesis typically yields peptides bound to Trifluoroacetate (TFA) counterions, we offer efficient post-synthesis ion-exchange chromatography. We can convert the peptide into an acetate or hydrochloride (HCl) salt form. This customization is highly valuable for research teams conducting specific in vitro cell culture assays where the presence of residual TFA ions could interfere with baseline cellular viability or signaling readouts.

10. What quality control steps are taken to prevent endotoxin contamination in your peptides?

Preventing biological contamination is a foundational element of our quality control matrix. Our synthesis loops are conducted under strict laboratory conditions utilizing sterile, automated fluidics. Final batches of the TB500 peptide undergo rigorous Limulus Amebocyte Lysate (LAL) testing to quantify the presence of bacterial endotoxins. We ensure that our research-grade peptides maintain an exceptionally low endotoxin threshold, typically ≤ 0.1 EU/mg. This clean biochemical profile ensures that your in vitro cellular assays do not experience confounding inflammatory spikes or non-specific receptor activation caused by microbial impurities.

11. Can you introduce fluorescent labels or tags to the TB500 peptide sequence?

Yes, our custom peptide synthesis department can integrate a wide variety of modifications, including fluorescent modifications and chemical tags, directly into the TB500 peptide chain. We can conjugate popular fluorophores such as Fluorescein Isothiocyanate (FITC), Rhodamine, or specific Alexa Fluor dyes at either the N-terminus or C-terminus, as well as introduce biotinylation for streptavidin-binding applications. These custom modifications are essential tools for advanced imaging studies, allowing research teams to track peptide localization, binding affinity, and cellular internalisation pathways via confocal microscopy or flow cytometry.

12. How does your facility determine the net peptide content of a TB500 batch?

Net peptide content is distinct from raw chromatographic purity and is determined via precise Amino Acid Analysis (AAA) or UV spectrophotometry. While HPLC purity measures the percentage of the desired peptide relative to total peptide impurities, net peptide content quantifies the actual weight percentage of peptide material in the lyophilized cake, excluding residual counterions and retained moisture. Understanding this exact percentage is crucial for quantitative laboratory calculations, allowing researchers to accurately weigh out raw lyophilized material and prepare precise molar concentrations for their physical chemistry and structural biology assays.

13. What is the turnaround time for a custom synthesis order of TB500 peptide?

The typical turnaround time for custom synthesis orders of TB500 peptide spans approximately 2 to 3 weeks, depending on the specific batch volume, required purity level, and any requested structural modifications or counterion exchanges. This timeline includes the initial solid-phase chain elongation, cleavage matrices, intensive multi-step preparative HPLC purification, freeze-drying lyophilization cycles, and comprehensive final quality control validation. We provide our B2B clients with transparent timeline updates throughout the synthesis lifecycle, ensuring your laboratory operations and project milestones can be scheduled with complete predictability.

14. Do you offer validation data for your HPLC analysis profiles?

Yes, all High-Performance Liquid Chromatography (HPLC) profiles generated by our analytical department adhere to strict industry validation standards. We utilize advanced reverse-phase systems running optimized acetonitrile/water gradients containing precise mobile-phase modifiers like TFA. The resulting chromatograms feature clear baseline separation, integrated peak areas, and high signal-to-noise ratios, confirming the absence of closely related deletion sequences or oxidized variants. This rigorous analytical validation ensures that the chemical purity percentage stated on your product documentation reflects a true, accurate representation of the material’s composition.

15. Are your TB500 peptide products suitable for clinical or diagnostic applications?

No, all TB500 peptide products supplied by our facility are manufactured and distributed strictly as research peptides for laboratory use only. They are intended solely for in vitro biochemical testing, molecular modeling, and localized in vivo animal research models within approved academic or industrial research environments. The material is not synthesized under current Good Manufacturing Practices (cGMP) for human administration or medical diagnostics. It should never be utilized for therapeutic, medical, or clinical applications under any circumstances. Laboratories must possess the appropriate containment and analytical infrastructure to handle these reagents safely.

References

1. Sanders, M. C., Goldstein, A. L., & Wang, Y. L. (1992). Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cells. Proceedings of the National Academy of Sciences, 89(10), 4678–4682.

   DOI: 10.1073/pnas.89.10.4678

2. Philp, D., Huff, T., Gho, Y. S., Hannappel, E., & Kleinman, H. K. (2003). The actin binding site on thymosin β4 promotes angiogenesis. The FASEB Journal, 17(14), 2103–2105.

   DOI: 10.1096/fj.03-0121fje

3. Xue, B., Leyrat, C., Grimes, J. M., & Robinson, C. V. (2014). Structural basis of thymosin-β 4/profilin exchange leading to actin filament polymerization. Proceedings of the National Academy of Sciences, 111(49), E5296–E5305.

   DOI: 10.1073/pnas.1412271111

4. Philp, D., Badamchian, M., Scheremeta, B., Nguyen, M., Goldstein, A. L., & Kleinman, H. K. (2003). Thymosin β 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair and Regeneration, 11(1), 19–24.

   DOI: 10.1046/j.1524-475x.2003.11105.x

5. Goldstein, A. L., Hannappel, E., & Kleinman, H. K. (2005). Thymosin β 4: Actin-sequestering protein and a multifunctional regenerative peptide. Vitamins & Hormones, 73, 241–274.

   DOI: 10.1016/S0083-6729(05)73008-0

6. Huff, T., Müller, C. S. G., Otto, A. M., Netzker, R., & Hannappel, E. (2001). β -Thymosins, small acidic peptides with multiple functions. The International Journal of Biochemistry & Cell Biology, 33(3), 205–220.

   DOI: 10.1016/S1357-2725(00)00087-X

7. Kleinman, H. K., & Sosne, G. (2016). Thymosin β 4 signaling pathways. Experimental Eye Research, 147, 140–145.

   DOI: 10.1016/j.exer.2016.03.017

8. Crockford, D., Turjman, N., Allan, C., & Angel, J. (2010). Thymosin β 4: Structure, function, and biological properties supporting current and future clinical applications. Annals of the New York Academy of Sciences, 1194(1), 179–189.

   DOI: 10.1111/j.1749-6632.2010.05492.x

9. McGuire, F., Hughes, E., Maak, T., & Cushman, D. M. (2026). Thymosin Beta-4 and TB-500 in tissue healing, regeneration, and musculoskeletal repair: A scoping review. Applied Sciences, 16(12), 6202.

   DOI: 10.3390/app16126202

10. Low, T. L., Hu, S. K., & Goldstein, A. L. (1981). Complete amino acid sequence of bovine thymosin β 4: A thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations. Proceedings of the National Academy of Sciences, 78(2), 1162–1166.

    DOI: 10.1073/pnas.78.2.1162